530233 AUROLAB

Auro Laboratories Share Price

₹232.00 +5.95 (2.63%)

23 Feb, 2025 04:14

SIP TrendupStart SIP in AUROLAB

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month -6.71%
  • Over 3 Month + 18.7%
  • Over 6 Month + 16.88%
  • Over 1 Year + 34.88%
SIP Lightning

Smart Investing Starts Here Start SIP with Auro Laboratories for Steady Growth!

Invest Now

Auro Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Auro Laboratories Financials

Auro Laboratories Technicals

EMA & SMA

Current Price
₹232.00
+ 5.95 (2.63%)
pointer
  • stock-down_img
  • Bearish Moving Average 4
  • stock-up_img
  • Bullish Moving Average 12
  • 20 Day
  • ₹224.89
  • 50 Day
  • ₹232.92
  • 100 Day
  • ₹229.74
  • 200 Day
  • ₹213.95

Resistance and Support

226.33 Pivot Speed
  • R3 269.37
  • R2 253.03
  • R1 242.67
  • S1 215.97
  • S2 199.63
  • S3 189.27

What's your outlook on Auro Laboratories?

You can only vote for once

Auro Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-02-14 Quarterly Results
2024-11-11 Quarterly Results
2024-08-09 Quarterly Results
2024-05-25 Audited Results
2024-02-06 Quarterly Results

Auro Laboratories F&O

Auro Laboratories Shareholding Pattern

No data available.

About Auro Laboratories

  • NSE Symbol
  • AUROLAB
  • BSE Symbol
  • 530233
  • ISIN
  • INE292C01011

Similar Stocks to Auro Laboratories

Auro Laboratories FAQs

Auro Laboratories share price is ₹232 As on 23 February, 2025 | 04:00

The Market Cap of Auro Laboratories is ₹144.6 Cr As on 23 February, 2025 | 04:00

The P/E ratio of Auro Laboratories is 41.5 As on 23 February, 2025 | 04:00

The PB ratio of Auro Laboratories is 3.4 As on 23 February, 2025 | 04:00

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23